Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Counseling plus tranexamic acid or mefenamic acid for bleeding/spotting with Mirena
2010-020922-16Phase 4Completed
- Sponsor
- Bayer
- Start
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in menstrual disorders comparing Tranexamic acid arm, Mefenamic acid arm and Placebo arm (3 arms). Primary endpoint: Cumulative number of bleeding/spotting days during double-blind treatment. Started Dec 2010; status: completed.
02
Drugs
tranexamic acidMefenamic acid
03
Conditions
menstrual disorders
Beyond the preview
Go deeper on 2010-020922-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020922-16.